Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 41Terminated 7Recruiting 2Active not recruiting 2Withdrawn 1No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 298Neoplasms 179Breast Neoplasms 169Colorectal Neoplasms 107Neoplasm Metastasis 99Melanoma 99Multiple Myeloma 93Prostatic Neoplasms 90Ovarian Neoplasms 83Recurrence 79Carcinoma, Renal Cell 73Lung Neoplasms 71Stomach Neoplasms 67Squamous Cell Carcinoma of Head and Neck 66Lymphoma, Non-Hodgkin 61Pancreatic Neoplasms 59Leukemia, Lymphocytic, Chronic, B-Cell 56Leukemia, Myeloid, Acute 54Carcinoma, Hepatocellular 48Triple Negative Breast Neoplasms 46Urinary Bladder Neoplasms 45Small Cell Lung Carcinoma 45Lymphoma, Large B-Cell, Diffuse 43Head and Neck Neoplasms 41Endometrial Neoplasms 41Lymphoma, Follicular 39Lymphoma 37Uterine Cervical Neoplasms 35Parkinson Disease 4, Autosomal Dominant Lewy Body 34Glioblastoma 34

Interventions

Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × INDUSTRY × Arthritis, Rheumatoid × Clear all
NCT03270982 2025-12-23

Comprehensive Segmental Revision System

Zimmer Biomet

Active not recruiting
105 enrolled

Arthritis, Rheumatoid, Neoplasms, Wounds and Injuries

NCT06175338 2024-09-19

Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis

Mabscale, LLC

Phase 1 Active not recruiting
208 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡